National Vision (EYE) reported $2.0B in revenue for fiscal 2025, +9.0% year on year. That ranks #1338 by revenue among 2853 SEC filers and #122 in Healthcare. Net income was $29.6M, a net margin of 1.5%. Revenue has grown 5.8% a year on average since 2016 ($1.2B then). The fiscal 2025 balance sheet shows $2.0B in total assets, $38.7M in cash and $223M in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $2.0B | +9.0% | FY20252026-01-03 |
| Gross profit | Not reported | — | |
| Operating incomeOperatingIncomeLoss | $58.8M | +$69.2M | FY20252026-01-03 |
| Net incomeNetIncomeLoss | $29.6M | +$58.1M | FY20252026-01-03 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $146M | +9.5% | FY20252026-01-03 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $72.8M | −23.7% | FY20252026-01-03 |
| Total assetsAssets | $2.0B | −1.2% | FY20252026-01-03 |
| Shareholders' equityStockholdersEquity | $870M | +6.5% | FY20252026-01-03 |
| CashCashAndCashEquivalentsAtCarryingValue | $38.7M | −47.7% | FY20252026-01-03 |
| Long-term debtLongTermDebtNoncurrent | $223M | −6.7% | FY20252026-01-03 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-04-04 | $544M | $31.2M | Open → |
| Q2 20262026-07-04 | $499M | $12.4M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 108 of 161 companies compared | 1.5% | |
| Operating marginRank 115 of 160 companies compared | 3.0% | |
| Cash as share of revenueRank 147 of 160 companies compared | 1.9% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- National Vision Holdings, Inc.
- Ticker
- EYE
- Exchange
- Nasdaq
- SIC classification
- Ophthalmic Goods (3851)
- Fiscal year end
- 01-02
- CIK
- 0001710155
Filings
- 10-QAug 13, 2026Open filing →
- 10-QMay 14, 2026Open filing →
- 10-KMar 4, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| QiagenQGEN | $2.1B | $425M |
| RadnetRDNT | $2.0B | −$18.7M |
| TeleflexTFX | $2.0B | −$906M |
| National VisionEYE | $2.0B | $29.6M |
| ModernaMRNA | $1.9B | −$2.8B |
| Clover Health InvestmentsCLOV | $1.9B | −$85.5M |
| Pediatrix MedicalMD | $1.9B | $165M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=National Vision — Key figures |url=https://companiesranked.com/en/company/national-vision |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). National Vision — Key figures. CompaniesRanked. https://companiesranked.com/en/company/national-visionBibTeX
@misc{companiesranked-en-company-national-vision-2026,
author = {{CompaniesRanked}},
title = {{National Vision — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/national-vision}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-014379 · March 4, 2026
{{cite web |title=National Vision — Key figures — 10-K (0001628280-26-014379) |url=https://www.sec.gov/Archives/edgar/data/1710155/000162828026014379/eye-20260103.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-04}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.